Surgeons should consider local therapies for recurrent pancreatic ductal adenocarcinoma as they show significant survival benefits. For liver-only recurrence, local therapy leads to longer survival than chemotherapy alone (HR 0.26). Surgical resection for lung-only recurrence offers better survival compared to conventional treatment (HR 0.35). Careful patient selection and tailored approaches could enhance outcomes in recurrence […]
Category: HPB & Spleen
Understanding Symptom Recovery After Pancreatectomy
Symptom recovery following pancreatectomy is crucial for optimizing patient outcomes. Overall recovery rates were 68.1% at one month, 78.6% at three months, and 86.9% at six months post-surgery. Top symptoms included pain, fatigue, sleep disturbance, drowsiness, and bloating; fatigue persisted the longest. Preventing postoperative complications is vital for improving recovery, regardless of surgical technique. Journal […]
Reassessing Malignancy Risks in Mixed-Type IPMNs
Mixed-type intraductal papillary mucinous neoplasms (IPMNs) have a lower malignancy risk than previously thought, affecting surgical decision-making. 46.5% of mixed-IPMNs showed malignancy, compared to 79.2% in main-duct and 33.9% in branch-duct IPMNs. In the absence of high-risk features, the malignancy rate for mixed-IPMNs dropped to 24.7%, similar to branch-duct IPMNs at 20.2%. Consider patient selection […]
New model distinguishes MD-IPMN from chronic pancreatitis
A new machine learning model using endoscopic ultrasound can differentiate main-duct intraductal papillary mucinous neoplasm (MD-IPMN) from chronic pancreatitis (CP), which is crucial for surgical decision-making. Key features to note: intraductal nodules (2.4% CP vs 20.0% MD-IPMN, p = .003) and ductal stones (77.1% CP vs 2.5% MD-IPMN, p < .001). The model achieved a […]
Upfront Endoscopic Necrosectomy Shows No Advantage Over Step-Up Approach
A systematic review finds no significant difference in outcomes between upfront endoscopic necrosectomy (UEN) and step-up endoscopic necrosectomy (SUEN) for walled-off pancreatic necrosis, influencing surgical decision-making. Clinical success rates were similar: RR 1.04 (95% CI, 0.98-1.11). Safety outcomes, including postprocedural bleeding and infection, also showed no significant differences. Surgeons should consider individual patient factors when […]
Study shows that evolving management of IPMNs affects cancer detection and surgical decisions.
Surveillance for IPMNs rose significantly, with 74% of 3,304 patients managed this way. Rates of high-grade dysplasia and invasive carcinoma increased after surveillance, with high-risk stigmata rising from 9% to 48%. Timely surgical intervention is crucial, as delayed resections may lead to worse outcomes. Overall, low-grade dysplasia decreased, but invasive cancer remains a concern, highlighting […]
Innovative Resection Technique for Liver Metastases
Surgeons can now consider double mini upper transversal hepatectomy for colorectal liver metastases involving major veins, previously deemed unresectable. This novel approach utilizes peripheral communicating veins to achieve an R0 resection while preserving liver functionality. Patients in this study faced no major complications and were discharged by postoperative day 12. This method expands surgical options […]
Laparoscopic Bile Duct Exploration Matches ERCP for Stones
Two leading treatments for choledocholithiasis—laparoscopic bile duct exploration (lbeps) and ERCP with laparoscopic cholecystectomy—show similar effectiveness, but surgeons can leverage their distinct recovery profiles. Both methods achieved 100% stone clearance with no conversions to open surgery, but lbeps showed quicker postoperative recovery of liver function tests. Patients receiving lbeps faced less acute cholangitis and had […]
Plastic and Metal Stents Show No Survival Difference in Pancreatic Cancer
Stent choice for preoperative biliary drainage in pancreatic cancer does not affect long-term survival. Among 6,429 patients, overall and recurrence-free survival were similar for plastic (PS) and metal stents (MS) after pancreaticoduodenectomy, even in those receiving neoadjuvant therapy. No significant difference in postoperative complications between PS and MS. Choose stents based on drainage duration and […]
New Peptide Strategy Outperforms Balloon for Post-ERCP Bleeding
A self-assembling peptide-first approach significantly enhances hemostasis for immediate post-sphincterotomy bleeding during ERCP. Successful initial hemostasis was achieved in 92.3% of the peptide group versus 76.9% in the balloon group (15.4% risk difference, p=0.027). The mean procedure time was shorter for the peptide strategy, and rescue devices were needed less often (7.7% vs 23.1%, p=0.033). […]
